Skip to main navigation Skip to main content Skip to page footer
9th February - International Greek Language Day

9TH FEBRUARY - INTERNATIONAL GREEK LANGUAGE DAY

Greek belongs to the Indo-European family of languages and has been spoken uninterruptedly in the eastern Mediterranean for at least thirty-five centuries, from the age of linear-B tablets and Homeric heroes to our times, the times of social media, greeklish and of an unprecedented expansion in the production and diffusion of the printed...

For the 5th consecutive year NKUA is in top 100 Universities of the World Ranking "Top Universities by Top Google Scholar Citations" of Webometrics

FOR THE 5TH CONSECUTIVE YEAR NKUA IS IN TOP 100 UNIVERSITIES OF THE WORLD RANKING "TOP UNIVERSITIES BY TOP GOOGLE SCHOLAR CITATIONS" OF WEBOMETRICS

For the 5th consecutive yearNKUA is in top 100 Universities of the World Ranking "Top Universities by Top Google Scholar Citations" of Webometrics

http:/webometrics.info/en/transparent      

On January 26, 2022, the results of Webometrics' "Top Universities by Top Google Scholar Citations" global ranking were announced. According to this...

Research Seminar: "Minimum Wages and Insurance within the Firm" (by Effrosyni (Efi) Adamopoulou)

RESEARCH SEMINAR: "MINIMUM WAGES AND INSURANCE WITHIN THE FIRM" (BY EFFROSYNI (EFI) ADAMOPOULOU)

Wednesday 19 January 2022
Pioneering international study on the treatment of metastatic melanoma with the participation of Mrs. Helen Gogas, Professor of the National and Kapodistrian University of Athens

PIONEERING INTERNATIONAL STUDY ON THE TREATMENT OF METASTATIC MELANOMA WITH THE PARTICIPATION OF MRS. HELEN GOGAS, PROFESSOR OF THE NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS

Pioneering international study on the treatment of metastatic melanoma with the participation of Mrs. Helen Gogas, Professor of the National and Kapodistrian University of Athens

New checkpoint inhibitor shows efficacy in metastatic melanoma

Following the durable remissions in metastatic melanoma patients induced by PD-1/PD-L1 inhibitors,...